Unlike last year, a large group of the top draft prospects in 2025 are playing collegiately, and most of them have led their ...

Mark Sears went to Hargrave Military Academy before he played for Alabama basketball. How military school shaped his path to ...

The Houston Rockets have been banged up for a good chunk of the season. Ever since Jabari Smith Jr. broke his hand in early January, the Rockets have yet to be fully healthy. When the team was all ...

The duo launched on a SpaceX Falcon 9 rocket at 11:10 p.m. EST (0310 March 12 GMT). There was a glimmer in the air tonight at Vandenberg Space Force Base in California, and it wasn't only because ...

Tight end Juwan Johnson has agreed to a three-year contract to re-sign with the New Orleans Saints, agent AJ Vaynerchuk announced on social media Tuesday. Johnson, 28, had a foot issue last summer ...

Standout freshmen continue to perform and fuel the hype around the 2025 NBA draft class. We moved two more into the top 10 after the way they closed out their regular seasons. Still, NBA teams ...

Missing injured guards Amen Thompson, Fred VanVleet and Reed Sheppard didn’t stop the shorthanded Houston Rockets from dominating the glass in a 97-84 win against the Orlando Magic on Monday ...

GameSpot may get a commission from retail offers. Developer Psyonix has announced a futuristic theme for Rocket League Season 18, with this new season kicking off on March 14. The season brings a ...

Rocket Cos. is pushing deeper into the property market with a deal to buy Redfin Corp. that values the real estate listing site at $1.75 billion. The Detroit-based financial technology group will ...

The payload is the next batch of SpaceX's Starlink internet satellites. As it flies into the night sky, the rocket will travel southeast from the launch pad. When is the next launch? Is there a ...

Tonight is Game 2 of a five-game road trip for the Orlando Magic (30-35) as they take the court in Houston against the Rockets (39-25). Orlando currently sits in eighth place in the Eastern Conference ...

Amgen’s $400 million eczema drug candidate has recorded two more phase 3 victories. The data drops provide more evidence that the Kyowa Kirin-partnered rocatinlimab improves outcomes in atopic ...